FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206248725> ?p ?o ?g. }

• W4206248725 endingPage "502" @default.
• W4206248725 startingPage "502" @default.
• W4206248725 abstract "Gamma-aminobutyric acid (GABA) is one of the inhibitory neurotransmitters. Several studies have suggested that GABA supplements can reduce blood pressure and modulate the renal immune system in vitro and in vivo. In the present study, we investigated the effect of GABA-enriched salt as an alternative to traditional salt on aggravated renal injury by high salt intake in cisplatin-induced nephrotoxicity mice. High salt intake accelerated the increase of biomarkers, such as blood urea nitrogen and serum creatinine levels for renal injury in cisplatin-induced nephrotoxicity mice. However, oral administration of GABA-contained salt notably suppressed serum BUN and creatinine levels. The efficacy of GABA salt was superior to lacto GABA salt and postbiotics GABA salt. Furthermore, GABA-enriched salt markedly restored histological symptoms of nephrotoxicity including renal hypertrophy, tubular dilation, hemorrhage, and collagen deposition aggravated by salt over-loading in cisplatin-exposed mice. Among them, GABA salt showed a higher protective effect against cisplatin-induced renal histological changes than lacto GABA salt and postbiotics GABA salt. In addition, administration of high salt significantly enhanced expression levels of apoptosis and inflammatory mediators in cisplatin-induced nephrotoxicity mice, while GABA-enriched salt greatly down-regulated the expression of these mediators. Taken together, these results demonstrate the protective effect of GABA against damage caused by high salt intake in cisplatin-induced renal toxicity. Its mechanism may be due to the suppression of hematological and biochemical toxicity, apoptosis, and inflammation. In conclusion, although the protective efficacy of GABA salt on renal injury is different depending on the sterilization and filtration process after fermentation with L. brevis BJ20 and L. plantarum BJ21, our findings suggest that GABA-enriched salt has a beneficial effect against immoderate high salt intake-mediated kidney injury in patients with cisplatin-induced nephrotoxicity." @default.
• W4206248725 created "2022-01-26" @default.
• W4206248725 creator A5009446618 @default.
• W4206248725 creator A5027754883 @default.
• W4206248725 creator A5032947799 @default.
• W4206248725 creator A5034278498 @default.
• W4206248725 creator A5042090068 @default.
• W4206248725 creator A5049276892 @default.
• W4206248725 creator A5066145486 @default.
• W4206248725 creator A5083877308 @default.
• W4206248725 creator A5086747371 @default.
• W4206248725 creator A5088866715 @default.
• W4206248725 creator A5091264153 @default.
• W4206248725 date "2022-01-03" @default.
• W4206248725 modified "2023-09-26" @default.
• W4206248725 title "Protective Effect of Gamma Aminobutyric Acid against Aggravation of Renal Injury Caused by High Salt Intake in Cisplatin-Induced Nephrotoxicity" @default.
• W4206248725 cites W131734353 @default.
• W4206248725 cites W1574905387 @default.
• W4206248725 cites W1964405385 @default.
• W4206248725 cites W1974051852 @default.
• W4206248725 cites W1981677188 @default.
• W4206248725 cites W1983965827 @default.
• W4206248725 cites W1985854311 @default.
• W4206248725 cites W1987604182 @default.
• W4206248725 cites W1995413692 @default.
• W4206248725 cites W2008222617 @default.
• W4206248725 cites W2030146812 @default.
• W4206248725 cites W2035332378 @default.
• W4206248725 cites W2045804567 @default.
• W4206248725 cites W2076990941 @default.
• W4206248725 cites W2079869133 @default.
• W4206248725 cites W2093316059 @default.
• W4206248725 cites W2097888088 @default.
• W4206248725 cites W2124756039 @default.
• W4206248725 cites W2127552400 @default.
• W4206248725 cites W2141541668 @default.
• W4206248725 cites W2146133266 @default.
• W4206248725 cites W2157388811 @default.
• W4206248725 cites W2169230321 @default.
• W4206248725 cites W2320983896 @default.
• W4206248725 cites W2322012484 @default.
• W4206248725 cites W2399486786 @default.
• W4206248725 cites W2604803316 @default.
• W4206248725 cites W2734417693 @default.
• W4206248725 cites W2737882528 @default.
• W4206248725 cites W2762527975 @default.
• W4206248725 cites W2883874550 @default.
• W4206248725 cites W2891654049 @default.
• W4206248725 cites W2928467655 @default.
• W4206248725 cites W2937766145 @default.
• W4206248725 cites W2964193653 @default.
• W4206248725 cites W2972713657 @default.
• W4206248725 cites W2973472262 @default.
• W4206248725 cites W2997973309 @default.
• W4206248725 cites W3012451273 @default.
• W4206248725 cites W3039401757 @default.
• W4206248725 cites W3081115211 @default.
• W4206248725 cites W3081622467 @default.
• W4206248725 cites W3087399576 @default.
• W4206248725 cites W3111056064 @default.
• W4206248725 cites W3115236410 @default.
• W4206248725 cites W3150252631 @default.
• W4206248725 cites W3176668137 @default.
• W4206248725 cites W3180431050 @default.
• W4206248725 cites W3187669107 @default.
• W4206248725 cites W3205903613 @default.
• W4206248725 cites W3213483601 @default.
• W4206248725 cites W4211136945 @default.
• W4206248725 cites W4250210754 @default.
• W4206248725 doi "https://doi.org/10.3390/ijms23010502" @default.
• W4206248725 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35008928" @default.
• W4206248725 hasPublicationYear "2022" @default.
• W4206248725 type Work @default.
• W4206248725 citedByCount "4" @default.
• W4206248725 countsByYear W42062487252022 @default.
• W4206248725 countsByYear W42062487252023 @default.
• W4206248725 crossrefType "journal-article" @default.
• W4206248725 hasAuthorship W4206248725A5009446618 @default.
• W4206248725 hasAuthorship W4206248725A5027754883 @default.
• W4206248725 hasAuthorship W4206248725A5032947799 @default.
• W4206248725 hasAuthorship W4206248725A5034278498 @default.
• W4206248725 hasAuthorship W4206248725A5042090068 @default.
• W4206248725 hasAuthorship W4206248725A5049276892 @default.
• W4206248725 hasAuthorship W4206248725A5066145486 @default.
• W4206248725 hasAuthorship W4206248725A5083877308 @default.
• W4206248725 hasAuthorship W4206248725A5086747371 @default.
• W4206248725 hasAuthorship W4206248725A5088866715 @default.
• W4206248725 hasAuthorship W4206248725A5091264153 @default.
• W4206248725 hasBestOaLocation W42062487251 @default.
• W4206248725 hasConcept C126189478 @default.
• W4206248725 hasConcept C126322002 @default.
• W4206248725 hasConcept C134018914 @default.
• W4206248725 hasConcept C185592680 @default.
• W4206248725 hasConcept C2776694085 @default.
• W4206248725 hasConcept C2778176769 @default.
• W4206248725 hasConcept C2778239845 @default.
• W4206248725 hasConcept C2780091579 @default.
• W4206248725 hasConcept C2780306776 @default.

• next